View in EDS HTML Full Text PDF Full Text

Switching to High-Dose Aflibercept (8 mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study.

Saved in:
Bibliographic Details
Title: Switching to High-Dose Aflibercept (8 mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study.
Authors: Funatsu, Masahiko1 (AUTHOR), Higashijima, Fumiaki1,2 (AUTHOR), Ariyoshi, Nobuaki1 (AUTHOR), Haraguchi, Aiko1,2 (AUTHOR), Wasai, Yuki1 (AUTHOR), Mikuni, Masanori1 (AUTHOR), Ohta, Manami1 (AUTHOR), Wakuta, Makiko1 (AUTHOR), Hirano, Shinji1 (AUTHOR), Yamauchi, Kazuhiko2 (AUTHOR), Kimura, Kazuhiro1 (AUTHOR) k.kimura@yamaguchi-u.ac.jp
Source: Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 6, p2210. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm15062210